FDA/ORA Bioresearch Monitoring Information Page
|
|
|
| |
|
|
| |
|
|
| |
-
Compliance Policy Guides - Bimo Related:
| 100.900 |
International Memoranda of Understanding (June, 1995) Link to FDA International Program WebSite |
| 120.100 |
Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities (CPG 7150.09) (July, 1991) |
| 130.300 |
FDA Access to Results of Quality Assurance Program Audits and Inspections (CPG 7151.02) (January 1996) |
|
| |
|
|
| |
-
Guidance for Industry:
| Good Laboratory Practice Regulations Management Briefings Post Conference Report |
August 1979 (HTML) |
n/a |
| GLP Questions and Answers |
HTML |
PDF, 52 KB |
| Computerized Systems Used In Clinical Trials |
April 1999 (HTML) |
PDF, 46 KB |
| Guidance: Exception from Informed Consent-Emergency Research |
August 2011 |
PDF, 300 KB
|
| The Radioactive Drug Research Committee: Human Research Without An Investigational New Drug Application - Guidance for Industry and Researchers |
August 2010 |
PDF, 276 KB |
|
| |
-
| Part 50--PROTECTION OF HUMAN SUBJECTS |
HTML |
| Part 56--INSTITUTIONAL REVIEW BOARDS |
HTML |
| Part 58--GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES |
HTML |
| Part 312--INVESTIGATIONAL NEW DRUG APPLICATION |
HTML |
| Part 320--BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS |
HTML |
| Part 511--NEW ANIMAL DRUGS FOR INVESTIGATIONAL USE |
HTML |
| Part 812--INVESTIGATIONAL DEVICE EXEMPTIONS |
HTML |
|
| |
-
Good Laboratory Practice (GLP) Resources:
| Comparison Chart of FDA, Environmental Protection Agency (EPA), and Organization for Economic Co-operation and Development (OECD) |
HTML |
PDF, 1.8 MB |
| Good Laboratory Practice (GLP), Proposed Rule, 11/19/1976 |
HTML N/A |
PDF, 6.2 MB |
| Good Laboratory Practice (GLP) Final Rule, 12/22/1978 |
HTML N/A |
PDF, 8.4 MB |
| Good Laboratory Practice (GLP), Proposed Rule, 10/29/1984 |
HTML |
PDF, 1.8 MB |
| Good Laboratory Practice (GLP), Amendment, Final Rule, 9/4/1987 |
HTML |
PDF, 3.2 MB |
OECD GLP Internet (Organization for Economic
Co-operation and Development) (Link to an external site, not part of the FDA web) |
|